Test Price
2,800 AED✅ Home Collection Available
HSPB8 Gene Neuronopathy (Distal Hereditary Motor Neuropathy Type 2A) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The HSPB8 Genetic Test sequences the entire coding region of the HSPB8 gene to identify pathogenic variants responsible for distal hereditary motor neuropathy type 2A (dHMN2A) – a rare, progressive neuromuscular disorder. This test provides essential molecular diagnosis, supports accurate genetic counseling, and helps differentiate dHMN2A from other hereditary neuropathies.
| Feature | Our HSPB8 NGS Test | Closest Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage | Sanger sequencing of selected exons only |
| Diagnostic Yield | >99.9% analytical sensitivity for all coding variants | ~85% – may miss deep intronic or regulatory mutations |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Result Utility | Comprehensive report aligned with DHA recommendations | Limited variant interpretation, often requiring reflex testing |
Physician Insight & Safety Protocols
Hereditary motor neuropathies can present with subtle, slowly progressive weakness; this genetic test is a powerful tool but must be correlated with a detailed neurological examination and family history. A negative result does not exclude other genetic or acquired neuropathies, and variants of uncertain significance require expert interpretation. I strongly recommend pre‑ and post‑test genetic counseling to fully understand the implications for you and your family.
Advisory
⛔ Do not discontinue any prescribed medication without consulting your doctor.
This test is a diagnostic aid and does not replace professional medical advice. Always consult your healthcare provider before making any changes to your treatment regimen.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Individuals under 18 years without legally authorized guardian consent; inability to provide informed consent; acute psychiatric instability affecting decision‑making capacity.
- ER Red Flags: Sudden worsening of muscle weakness, difficulty breathing or swallowing, acute new‑onset foot drop or hand atrophy, or any rapidly progressive neurological deficit – seek immediate emergency medical attention.
Patient FAQ & Clinical Guidance
1. What is the HSPB8 gene test and why do I need it?
A: HSPB8 gene sequencing detects pathogenic mutations in the HSPB8 gene causing distal hereditary motor neuropathy type 2A, enabling accurate diagnosis and personalized care. This test confirms the molecular cause of progressive distal limb weakness and atrophy, differentiates it from other neuromuscular conditions, and informs family screening and reproductive planning. A genetic counseling session is arranged beforehand to map your family pedigree and discuss potential outcomes.
2. How is the sample collected and when will I get the results?
A: A small blood sample, extracted DNA, or a dried blood spot on an FTA card is collected comfortably at your home by a certified phlebotomist; results are delivered within 3–4 weeks. Our VIP mobile phlebotomy team operates daily from 8 AM to 11 PM, ensuring specimen integrity via cold‑chain transport. You will receive a secure digital report and a post‑test teleconsultation to interpret your findings.
3. Is the HSPB8 test covered by insurance in the UAE?
A: Insurance coverage varies by provider and policy; we offer direct billing verification via WhatsApp at +971 54 548 8731 before scheduling the test. Our team will check your benefits under DHA‑regulated health plans and assist with pre‑authorization if required. Self‑pay options are also available at a transparent all‑inclusive rate of 2800 AED.
4. What are the risks and limitations of this genetic test?
A: The test requires a standard blood draw, which carries minimal risks such as bruising or discomfort. Genetic results may reveal information about other family members, and variants of uncertain significance may require further interpretation. Pre- and post-test genetic counseling is mandatory to address these implications.
UAE Regulatory & Data Privacy Adherence
This service complies with UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Laboratory operations are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). All genetic data is processed within a secure, DHA‑adherent infrastructure.
Clinical & Logistical Metadata
| Test Name | HSPB8 Gene Mutation Analysis (Distal Hereditary Motor Neuropathy Type 2A) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or dried blood spot |
| Methodology Used | Next‑Generation Sequencing (NGS) – full coding region coverage |
| ICD-10-CM Code | G12.21 |
| LOINC Code | 82939-0 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians